Resultats globals: 1 registres trobats en 0.01 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
7 p, 820.3 KB Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation / Stein, A. S. (Gehr Family Center for Leukemia Research. City of Hope) ; Kantarjian, H. (The University of Texas M.D. Anderson Cancer Center) ; Gökbuget, N. (Department of Medicine II. Goethe University) ; Bargou, R. C. (Comprehensive Cancer Center Mainfranken. University Hospital Würzburg) ; Litzow, Mark R (Mayo Clinic) ; Rambaldi, Alessandro (Department of Oncology and Hemato-Oncology. University of Milan and Azienda Pope John XXIII Hospital) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zhang, A. (Amgen Inc.) ; Zimmerman, Z. (Amgen Inc.) ; Zugmaier, Gerhard (Amgen Research Munich) ; Topp, M. S. (Medical Clinic and Polyclinic II. University Hospital Würzburg) ; Universitat Autònoma de Barcelona
Patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) following allogeneic hematopoietic stem cell transplantation (alloHSCT) have a poor prognosis, and alternative therapies are needed for this patient population. [...]
2019 - 10.1016/j.bbmt.2019.04.010
Biology of blood and marrow transplantation, Vol. 25 Núm. 8 (august 2019) , p. 1498-1504  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.